소 류코시스 진단용 래피드 키트
    12.
    发明授权
    소 류코시스 진단용 래피드 키트 有权
    用于小型白血病诊断的快速试剂盒

    公开(公告)号:KR101793267B1

    公开(公告)日:2017-11-03

    申请号:KR1020150042457

    申请日:2015-03-26

    Abstract: 본발명은소 류코시스진단용래피드키트및 이를이용한소 류코시스진단방법을제공한다. 본발명의키트를이용하면신속면역크로마토그라피법을이용하여, 특별한검사장비없이현장에서간편하고신속하게소 류코시스바이러스감염여부를진단할수 있다. 본발명의키트는소 류코시스바이러스에특이적인단일클론항체를이용하므로민감도및 특이도면에서우수한성능을보이며, 골드리더기를사용하여수치로결과표현이가능하기때문에육안으로확인하는기존키트보다편리하고정확한판정이가능하다.

    Abstract translation: 本发明提供了用于小型白血病诊断的快速试剂盒和使用其的小型白血病诊断方法。 使用本发明的试剂盒,可以使用快速免疫色谱法来在现场无需特殊测试设备的情况下容易且快速地诊断感染性结肠病毒感染。 由于本发明的试剂盒使用特异于小白血病病毒的单克隆抗体,因此其灵敏度和特异性表现出优异的表现,并且可以使用金阅读器以数值表示,因此, 准确的判断是可能的。

    BEI로 불활화된 일본뇌염 바이러스 KV1899주 항원 및 돼지의 GM-CSF 재조합 단백질을 포함하는 일본뇌염 불활화 백신 조성물
    14.
    发明公开
    BEI로 불활화된 일본뇌염 바이러스 KV1899주 항원 및 돼지의 GM-CSF 재조합 단백질을 포함하는 일본뇌염 불활화 백신 조성물 有权
    包含日本ENCEPHALITIS病毒的灭活疫苗组合物由二亚乙基胺和SWINE GM-CSF重组蛋白激活的病毒KV1899菌株抗原

    公开(公告)号:KR1020140014594A

    公开(公告)日:2014-02-06

    申请号:KR1020120081000

    申请日:2012-07-25

    CPC classification number: A61K38/1709 A61K39/12 C07K14/47 C12N15/63

    Abstract: The present invention relates to an inactivated vaccine composition for Japanese encephalitis containing Japanese encephalitis virus KV1899 strain antigens inactivated by BEI (binaryethyleneimine) and swine GM-CSF recombinant protein. The Japanese encephalitis virus KV1899 strain antigens inactivated by BEI and the swine GM-CSF recombinant protein have excellent immunogenicity, are suitable for the production of a vaccine by being mass-produced in insect cells, and match the genotype of genotype 1 Japanese encephalitis virus to be used as an effective vaccine for Japanese encephalitis without the problems of an existing live vaccine for Japanese encephalitis.

    Abstract translation: 本发明涉及含有BEI(二亚甲基亚胺)和猪GM-CSF重组蛋白失活的日本脑炎病毒KV1899菌株抗原的日本脑炎灭活疫苗组合物。 由BEI和猪GM-CSF重组蛋白质灭活的日本脑炎病毒KV1899菌株抗原具有优异的免疫原性,适用于通过在昆虫细胞中大批量生产疫苗,并将基因型1日本脑炎病毒的基因型与 用作日本脑炎的有效疫苗,没有现有的日本脑炎活疫苗的问题。

    토끼 출혈병변이주 바이러스 혈구응집용 항원 및 유전자 재조합불활화백신의 제조방법
    16.
    发明公开
    토끼 출혈병변이주 바이러스 혈구응집용 항원 및 유전자 재조합불활화백신의 제조방법 有权
    使用重组VP60细菌病毒治疗RABBIT HAMORRHAGIC疾病变种病毒的抗原和重组灭活疫苗的方法

    公开(公告)号:KR1020120036055A

    公开(公告)日:2012-04-17

    申请号:KR1020100097724

    申请日:2010-10-07

    Abstract: PURPOSE: A method for preparing an antigen for hemagglutination of rabbit hemorrhagic disease variant virus and recombinant inactivated vaccine is provided to reduce biological risk. CONSTITUTION: An antigen for suppressing hemagglutination is prepared by inoculating recombinant baculovirus prepared from VP60 gene(deposit number: KCTC 11756BP) of rabbit hemorrhagic disease variant virus into tissue culture cells. The tissue cultured cell is an insect cell(sf-9cell). A method for manufacturing an recombinant inactivated vaccine comprises: a stepo f cloning VP60 genes into pGEM-T vector; a step of cloning to pBuleBacHis4.5 vector to prepare recombinant baculovirus; a step of inoculating the baculovirus into the insect cells to prepare VP gene recombinant protein; a step of isolating antigen from the recombinant protein; and a step of inactivating the antigen.

    Abstract translation: 目的:提供兔出血性疾病变异病毒和重组灭活疫苗血细胞凝集抗原的制备方法,以降低生物学风险。 构成:通过将由兔出血性疾病变异病毒的VP60基因(保藏号:KCTC 11756BP)制备的重组杆状病毒接种到组织培养细胞中,制备用于抑制血细胞凝集的抗原。 组织培养细胞是昆虫细胞(sf-9细胞)。 制备重组灭活疫苗的方法包括:将VP60基因克隆到pGEM-T载体中; 克隆到pBuleBacHis4.5载体以制备重组杆状病毒的步骤; 将杆状病毒接种入昆虫细胞以制备VP基因重组蛋白的步骤; 从重组蛋白分离抗原的步骤; 和使抗原失活的步骤。

    소 IgG의 Fc 도메인의 세포 표면 발현용 벡터, 상기 벡터에 의해 형질전환된 숙주세포 및 상기 숙주세포를 이용한 소 질병 관련 바이러스에 대한 백신의 제조방법
    18.
    发明公开
    소 IgG의 Fc 도메인의 세포 표면 발현용 벡터, 상기 벡터에 의해 형질전환된 숙주세포 및 상기 숙주세포를 이용한 소 질병 관련 바이러스에 대한 백신의 제조방법 有权
    BOVINE IGG FC DOMIAN的细胞表面表达载体,用载体转化的宿主细胞和使用宿主细胞与CAT病毒相关的病毒的疫苗的制造方法

    公开(公告)号:KR1020100035054A

    公开(公告)日:2010-04-02

    申请号:KR1020080094356

    申请日:2008-09-25

    Abstract: PURPOSE: A vector for expressing IgG Fc domain on cell surface is provided to easily produce a vaccine having excellent immunogenicity to virus relating to bovine diseases. CONSTITUTION: A vector for expressing bovine IgG Fc domain contains a gene encoding the IgG Fc domain and gene encoding transmembrane domain of bovine transferring receptor. The gene encoding the transmembrane domain of bovine transferring receptor comprises a sequence of sequence number 5. The gene encoding Fc domain is a gene encoding hinge, CH2 and CH3. A method for manufacturing the vaccine to bovine disease-relating virus comprises: a step of infecting bovine disease-relating virus to a host cell using the expression vector to proliferate the virus; and a step of manufacturing the live vaccine or inactivated vaccine. The virus is bovine viral diarrhea virus (BVDV), ephemeral fever virus (BEF), bovine corona virus (BCV), bovine rotavirus (BoRotaV), bovine rhi notracheitis virus (IBRV), foot-and-mouth disease virus (FMDV), bovine parainfluenza virus (PI-3), blue tongue virus (BTV), bovine leukemia virus (BLV), cattle respirator syncytia virus (BRSV), akabane virus (AKV) or Ibaraki virus (IBV).

    Abstract translation: 目的:提供用于在细胞表面上表达IgG Fc结构域的载体,以容易地产生对与牛疾病有关的病毒具有优异免疫原性的疫苗。 构成:用于表达牛IgG Fc结构域的载体含有编码IgG Fc结构域的基因和编码牛转移受体的跨膜结构域的基因。 编码牛转移受体的跨膜结构域的基因包含序列号5的序列。编码Fc结构域的基因是编码铰链,CH2和CH3的基因。 用于制造与牛疾病相关的病毒的疫苗的方法包括:使用表达载体将病毒相关病毒感染宿主细胞以增殖病毒的步骤; 以及制造活疫苗或灭活疫苗的步骤。 该病毒是牛病毒性腹泻病毒(BVDV),短暂热病毒(BEF),牛冠状病毒(BCV),牛轮状病毒(BoRotaV),牛病毒性气管炎病毒(IBRV),口蹄疫病毒(FMDV) 牛副流感病毒(PI-3),蓝舌病毒(BTV),牛白血病病毒(BLV),牛呼吸器合胞病毒(BRSV),阿卡巴因病毒(AKV)或茨巴病毒(IBV))。

Patent Agency Ranking